STUB1 Knockout HeLa Cell Line
Cat.No.:
EDC90406
Species:
Human
Cell Name:
HeLa
Gene:
STUB1
Gene ID:
10273
Size:
1×10⁶ cells
STUB1 Knockout Cell Line (Hela) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC90406 |
|---|---|
| Product Name | STUB1 Knockout Hela Cell Line |
| Cell Line | Hela |
| Cellosaurus ID | CVCL_0030 |
| Cell Line Synonyms | HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
| Gene | STUB1 |
| NCBI Gene ID | |
| Gene Synonyms | CHIP|HSPABP2|NY-CO-7|SCA48|SCAR16|SDCCAG7|UBOX1 |
| Summary |
This gene encodes a protein containing tetratricopeptide repeat and a U-box that functions as a ubiquitin ligase/cochaperone. The encoded protein binds to and ubiquitinates shock cognate 71 kDa protein (Hspa8) and DNA polymerase beta (Polb), among other targets. Mutations in this gene cause spinocerebellar ataxia, autosomal recessive 16. Alternative splicing results in multiple transcript variants. There is a pseudogene for this gene on chromosome 2. [provided by RefSeq, Jun 2014]
|
| Associated Diseases | Cervical Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5, 2days |
| Complete Culture Medium | MEM + 10% FBS |
| Freezing Medium | 70% Complete culture medium+ 20% FBS+ 10% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HeLa | STR Info (Cell bank) Cell Line: HeLa | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 9 | 10 | 9 | 10 |
| D1S1656 | 12 | 15 | 12 | 15 |
| D2S1338 | 17 | 17 | ||
| D3S1358 | 15 | 18 | 15 | 18 |
| D5S818 | 11 | 12 | 11 | 12 |
| D6S1043 | 18 | 18 | ||
| D7S820 | 8 | 12 | 8 | 12 |
| D8S1179 | 12 | 13 | 12 | 13 |
| D12S391 | 20 | 25 | 20 | 25 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 10 | 9 | 10 |
| D18S51 | 16 | 16 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 27 | 28 | 27 | 28 |
| FGA | 18 | 21 | 18 | 21 |
| Penta D | 8 | 15 | 8 | 15 |
| Penta E | 7 | 17 | 7 | 17 |
| TPOX | 8 | 12 | 8 | 12 |
| VWA | 16 | 18 | 16 | 18 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying STUB1 function, STUB1 Knockout HeLa Cell Line or STUB1 overexpression HeLa Cell Line?
The choice depends on whether you are studying CHIP's role as a co-chaperone E3 ubiquitin ligase for HSP70/HSP90 client proteins or its functions in protein quality control. The Knockout line is the standard tool for asking whether CHIP is required for ubiquitination of misfolded HSP70/HSP90 clients — its principal characterized function in proteostasis. Overexpression is useful for testing whether elevated CHIP enhances client protein degradation or for studying CHIP mutations associated with autosomal recessive spinocerebellar ataxia 16 (SCAR16).
For protein quality control research, the EDITGENE STUB1/CHIP Knockout in HeLa is a tractable platform with established HSP70/HSP90 client biology. Rescue with wild-type, U-box-deleted (E3 ligase-dead), or TPR-domain-mutant (chaperone-binding-deficient) CHIP enables dissection of E3 ligase versus co-chaperone functions. SCAR16-associated mutations can be introduced for disease modeling.
What are the application scenarios for this model?
Primary applications:
• HSP70/HSP90 client stability: cycloheximide chase analysis for HSP90 client proteins (ErbB2, AR, mutant p53, others) to assess CHIP-dependent degradation.
• Protein quality control: misfolded protein clearance assays following thermal stress or proteasome inhibition challenges.
• In vitro ubiquitination: reconstitution assays with purified CHIP and HSP70/HSP90-bound substrates for biochemical characterization.
• SCAR16 disease modeling: rescue with autosomal recessive cerebellar ataxia-associated STUB1 mutations enables genotype-phenotype correlation studies.
EDITGENE recommends this model for researchers investigating protein quality control biology, co-chaperone E3 ligase function, and SCAR16 disease mechanisms.
Is this STUB1 Knockout HeLa Cell Line compatible with overexpression rescue experiments?
Yes. CHIP rescue experiments are well-established given the maturity of HSP70/HSP90 quality control research:
• Construct design: use a codon-modified STUB1 sequence with a small C-terminal tag (FLAG, HA). CHIP's N-terminal TPR domain binds HSP70/HSP90 EEVD motifs and C-terminal U-box mediates E3 ligase activity — both must be preserved.
• U-box-deleted rescue: U-box mutation or deletion abolishes E3 ligase activity while preserving co-chaperone binding — the standard control for distinguishing ligase from chaperone-modulating functions.
• TPR-mutant rescue: TPR domain mutations (e.g., K30A) disrupt HSP70/HSP90 binding without affecting U-box activity, enabling dissection of substrate-targeting from catalytic functions.
• SCAR16 disease mutation rescue: introduction of autosomal recessive cerebellar ataxia 16-associated STUB1 mutations enables genotype-function correlation studies.
HeLa transduces efficiently with lentivirus and is one of the most widely used cell lines for protein quality control research, with extensive established protocols for CHIP rescue experiments.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download